Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Long-Term Extension Trial of a Novel Therapeutic Aryl Hydrocarbon Receptor Modulating Agent

Main Article Content

Bruce Strober
Linda Stein Gold
Robert Bissonnette
April Armstrong
Andrew Blauvelt
Philip Brown
Leon Kircik
Anna Tallman
Mark Lebwohl


tapinarof, psoriasis, long term extension trial




1. Lebwohl M, et al. Skin. 2020;4(6):s75;

2. Robbins K et al. J Am Acad Dermatol. 2019;80:714–721;

3. Strober B, et al. Innovations in Dermatology Virtual Spring Conference 2021, Poster Presentation,
March 16–20, 2021.

Most read articles by the same author(s)

<< < 18 19 20 21 22 23 24 25 26 > >>